CVE-2025-61885 is a vulnerability identified in Oracle Life Sciences InForm version 7.0.1.0, specifically within its web server component. The flaw allows an attacker with low privileges and network access via HTTP to read a subset of data accessible through the application without requiring user interaction or elevated privileges beyond low-level access. The vulnerability is classified under CWE-200, indicating an information exposure issue. The attack vector is network-based (AV:N), with low attack complexity (AC:L), requiring low privileges (PR:L), and no user interaction (UI:N). The impact is limited to confidentiality (C:L), with no effect on integrity (I:N) or availability (A:N). This means an attacker can extract some sensitive data but cannot modify or disrupt the system. The CVSS 3.1 base score of 4.3 reflects a medium severity level. Although no exploits are currently known in the wild, the vulnerability is easily exploitable due to the low complexity and network accessibility. Oracle Life Sciences InForm is widely used in clinical trial data management, making the confidentiality breach particularly concerning for sensitive clinical data. The absence of a patch link suggests that a fix may not yet be publicly available, emphasizing the importance of interim mitigations.

For European organizations, especially those involved in pharmaceutical research, clinical trials, and healthcare data management, this vulnerability poses a risk of unauthorized disclosure of sensitive clinical data. Such exposure can lead to regulatory non-compliance with GDPR and other data protection laws, reputational damage, and potential financial penalties. Although the vulnerability does not allow data modification or service disruption, the confidentiality breach could undermine patient privacy and intellectual property protection. Organizations relying on Oracle Life Sciences InForm version 7.0.1.0 may face targeted attacks aiming to extract proprietary clinical trial data or patient information. The impact is heightened in Europe due to stringent data privacy regulations and the significant presence of life sciences companies. The medium severity rating suggests that while the threat is not critical, it requires timely attention to prevent data leaks that could have legal and operational consequences.

1. Restrict network access to Oracle Life Sciences InForm web server to trusted internal networks and VPNs only, minimizing exposure to untrusted networks. 2. Implement strict access controls and monitor user privileges to ensure only authorized low-privilege accounts exist. 3. Deploy web application firewalls (WAF) with rules tailored to detect and block suspicious HTTP requests targeting the InForm application. 4. Conduct regular audits and monitoring of HTTP traffic logs for unusual access patterns or data exfiltration attempts. 5. Engage with Oracle support to obtain patches or security updates as soon as they become available and apply them promptly. 6. If patching is not immediately possible, consider isolating the affected system or using network segmentation to limit potential attacker movement. 7. Educate security teams about this specific vulnerability to enhance detection and response capabilities. 8. Review and enhance data encryption and masking within the application to reduce the impact of unauthorized read access.